Keywords
3-(2,2,2-trimethylhydrazine)propionate; cardiovascular agent; carnitine; immunological adjuvant; methylhydrazine derivative; animal; blood; cardiovascular disease; human; procedures; randomized controlled trial (topic); Adjuvants, Immunologic; Animals; Cardiovascular Agents; Cardiovascular Diseases; Carnitine; Humans; Methylhydrazines; Randomized Controlled Trials as Topic